JOHN L. CAMERON, Med 1962, the Alfred Blalock Professor of Surgery, Distinguished Service Professor, and the first William Stewart Halsted Professor of Surgery, stepped down in 2003 as surgeon-in-chief and chairman of the Department of Surgery. He has made many contributions to the understanding of the pathophysiology and management of benign and malignant pancreatic diseases. Most often associated with the Whipple procedure, a complex operation used to treat a variety of pancreatic diseases including pancreatic cancer, he has performed more of these operations than any other surgeon in the world. Except for two years at the Walter Reed Army Institute of Research, Dr. Cameron has spent his entire medical career at Johns Hopkins. He has published over 300 articles, over 90 book chapters, and is the editor of nine books. He is on the editorial board of several journals, is co-editor of the Journal of Gastrointestinal Surgery and is editor of Advances in Surgery. Dr. Cameron remains active as a clinical surgeon, as a teacher, and an investigator.   FRED HITTMAN, who died in 2002, was a pioneer in the implantable medical device industry. He developed the concept of hermetic feedthrough, making it possible to seal pacemakers into a titanium case, providing immunity from invasion by body fluids. Every pacemaker, defibrillator, neurostimulator, and implantable hearing device in the world uses this sealing concept today. SANDRA HITTMAN attended the Peabody Institute and served on its faculty. She continues her strong involvement with the university as a member of the Peabody Advisory Council.

RICHARD D. SCHULICK, Engr 1985, Med 1989, the John L. Cameron, M.D., Professor of Alimentary Tract Diseases, is an associate professor of surgery, oncology, and gynecology and obstetrics at the Johns Hopkins University School of Medicine. Dr. Schulick is an attending surgeon at The Johns Hopkins Hospital and is the chief of the John L. Cameron, M.D., Surgical Oncology Service and director of the Hepaticopancreaticobiliary Fellowship. He has also completed fellowship training in clinical pharmacology and immunology, both at the National Institutes of Health in Bethesda, Maryland; advanced gastrointestinal surgery at Johns Hopkins; and surgical oncology at Memorial Sloan-Kettering Cancer Center in New York. His clinical interests are cancers and tumors of the pancreas, liver, bile duct, gallbladder, colon and adrenals. He also leads a tumor immunology and vaccine development program.